Principales diferencias farmacodinámicas y afinidad sobre los receptores entre los inhibidores de la recaptación de serotonina-noradrenalina: implicaciones clínicas en el manejo del dolor neuropático
Autores:Antonio Alcántara Montero, A. González Curado
Main pharmacodynamic differences and receptor affinities between serotonin-norepinephrine reuptake inhibitors: clinical implications in the management of neuropathic pain
Bymaster, FP,Dreshfield-Ahmad, LJ,Threlkeld, PG,Shaw, JL,Thompson, L,Nelson, DL. (2001). Comparative affinity of duloxetine and venlafaxine...
Raouf, M,Glogowski, AJ,Bettinger, JJ,Fudin, J. (2017). Serotonin-norepinephrine reuptake inhibitors and the influence of binding affinity...
(2017). Venlafaxina MedP EU-FT.
Grothe, DR,Scheckner, B,Albano, D. (2004). Treatment of pain syndromes with venlafaxine. Pharmacotherapy. 24. 621
Rowbotham, MC,Goli, V,Kunz, NR,Lei, D. (2004). Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double blind,...
Tasmuth, T,Härtel, B,Kalso, E. (2002). Venlafaxine in neuropathic pain following treatment of breast cancer. Eur J Pain. 6. 17-24
Durand, JP,Deplanque, G,Montheil, V,Gornet, JM,Scotte, F,Mir, O. (2012). Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced...
Zimmerman, C,Atherton, PJ,Pachman, D,Seisler, D,Wagner-Johnston, N,Dakhil, S. (2016). MC11C4: a pilot randomized, placebo-controlled, double-blind...